Enfermidades Autoinmunes y Tromboses
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublications in collaboration with researchers from Hospital Universitari de Bellvitge (5)
2023
-
Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies
Rheumatology (United Kingdom), Vol. 62, Núm. 1, pp. 243-255
2022
-
Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial
Journal of Clinical Medicine, Vol. 11, Núm. 19
-
Survey on the management of Pompe disease in routine clinical practice in Spain
Orphanet Journal of Rare Diseases, Vol. 17, Núm. 1
2017
-
Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis
Clinical and Experimental Rheumatology, Vol. 35, pp. S98-S105
2006
-
Enfermedad de Fabry en España: Primer análisis de la respuesta al tratamiento de sustitución enzimática
Medicina Clinica, Vol. 127, Núm. 13, pp. 481-484